An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract NPC Fernandes, CV Lagishetty, VS Panda, SR Naik BMC complementary and alternative medicine 7, 1-8, 2007 | 342 | 2007 |
Polyamines: potential anti-inflammatory agents and their possible mechanism of action CV Lagishetty, SR Naik Indian journal of pharmacology 40 (3), 121, 2008 | 72 | 2008 |
A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: application … L Chakradhar, R Kallem, A Karthik, BT Sundari, S Ramesh, R Mullangi, ... Biomedical Chromatography 22 (1), 58-63, 2008 | 38 | 2008 |
Effects of temsavir, active moiety of antiretroviral agent fostemsavir, on QT interval: results from a phase I study and an exposure–response analysis C Lagishetty, K Moore, P Ackerman, C Llamoso, M Magee Clinical and Translational Science 13 (4), 769-776, 2020 | 23 | 2020 |
Simultaneous semimechanistic population analyses of levofloxacin in plasma, lung, and prostate to describe the influence of efflux transporters on drug distribution following … ES Zimmermann, JV Laureano, CN dos Santos, S Schmidt, CV Lagishetty, ... Antimicrobial agents and chemotherapy 60 (2), 946-954, 2016 | 22 | 2016 |
Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples … RR Kallem, A Karthik, L Chakradhar, R Mullangi, NR Srinivas Arzneimittelforschung 57 (11), 705-711, 2007 | 21 | 2007 |
Current strategies to streamline pharmacotherapy for older adults JF Schlender, V Vozmediano, AG Golden, M Rodriguez, TS Samant, ... European Journal of Pharmaceutical Sciences 111, 432-442, 2018 | 18 | 2018 |
How Informative Are Drug‐Drug Interactions of Gene‐Drug Interactions? CV Lagishetty, J Deng, LJ Lesko, H Rogers, M Pacanowski, S Schmidt The Journal of Clinical Pharmacology 56 (10), 1221-1231, 2016 | 14 | 2016 |
Polyamines in inflammation and their modulation by conventional anti-inflammatory drugs L Chakradhar V, SR Naik CSIR, 2007 | 13 | 2007 |
Evaluation of approaches to deal with low-frequency nuisance covariates in population pharmacokinetic analyses CV Lagishetty, SB Duffull The AAPS journal 17, 1388-1394, 2015 | 9 | 2015 |
A reduction in between subject variability is not mandatory for selecting a new covariate CV Lagishetty, P Vajjah, SB Duffull Journal of pharmacokinetics and pharmacodynamics 39 (4), 383-392, 2012 | 6 | 2012 |
Design of pharmacokinetic studies for latent covariates CV Lagishetty, CV Coulter, SB Duffull Journal of pharmacokinetics and pharmacodynamics 39, 87-97, 2012 | 6 | 2012 |
Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children S Jiang, K Madrasi, T Samant, C Lagishetty, V Vozmediano, A Chiew, ... The Journal of Clinical Pharmacology 60 (5), 595-604, 2020 | 4 | 2020 |
Probable Mechanism of the Antihyperglycemic Effect of Standardized Extract from Momordica charantia in Streptozotocin Diabetic Rats SR Naik, SB Bumrela, CV Lagishetty, RV Mandlik Journal of Complementary and Integrative Medicine 6 (1), 2009 | 4 | 2009 |
The personalization of drug therapy for elderly patients JF Schlender, AG Golden, TS Samant, CV Lagishetty, S Schmidt Developing Drug Products in an Aging Society: From Concept to Prescribing …, 2016 | 3 | 2016 |
Are We Getting the Best Return on Investment From Clinical Drug‐Drug Interaction Studies? LJ Lesko, CV Lagishetty The Journal of Clinical Pharmacology 56 (5), 555-558, 2016 | 2 | 2016 |
Covariates in pharmacometrics C Lagishetty University of Otago, 2013 | 1 | 2013 |
Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Characterization of Dolutegravir/Rilpivirine Two‐Drug Regimen in the SWORD‐1/‐2 Phase 3 Studies R Mehta, CV Lagishetty, K Angelis, A Aylott, L Kahl, L Blair, J Mathews, ... British Journal of Clinical Pharmacology, 2023 | | 2023 |
Human Systemic Exposure Prediction of GSK2981278 following topical administration using Ex Vivo Human Skin Penetration and Allometric Based Scaling for Dose Determination CV Lagishetty, LL Santos, J Speitel, C Booth-Genthe, R Singh JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S14-S14, 2018 | | 2018 |
Pharmacokinetic and pharmacodynamic drug interaction between flibanserin and fluconazole CV Lagishetty, TS Samant, L Ge, MN Trame, K Natarajan, J Yuan, ... DRUG METABOLISM REVIEWS 48, 77-77, 2016 | | 2016 |